» Articles » PMID: 35636818

Analytic and Clinical Performance of Major Commercial Severe Acute Respiratory Syndrome Coronavirus 2 Molecular Assays in the United States

Overview
Journal Clin Lab Med
Specialty Pathology
Date 2022 May 31
PMID 35636818
Authors
Affiliations
Soon will be listed here.
Abstract

The rapid development of commercially available molecular assays in response to the COVID-19 pandemic has been essential in identifying positive cases and guiding state and national response plans. With over 200 SARS-CoV-2 molecular tests having received emergency use authorization by the US Food and Drug Administration, numerous studies have been conducted to evaluate these methods and compare their analytical and clinical performance. By applying the lessons learned from the rapid development of molecular assays in response to the COVID-19 pandemic, the diagnostic industry will be better prepared to respond to future outbreaks of novel infectious diseases.

Citing Articles

Authorized SARS-CoV-2 molecular methods show wide variability in the limit of detection.

Blommel J, Jenkinson G, Binnicker M, Karon B, Boccuto L, Ivankovic D Diagn Microbiol Infect Dis. 2023; 105(3):115880.

PMID: 36669396 PMC: 9751006. DOI: 10.1016/j.diagmicrobio.2022.115880.


Design and Innovation of Piano Impromptu Accompaniment for College Music Performance Majors under the Information Environment.

Wang Y J Environ Public Health. 2022; 2022:5245256.

PMID: 35844941 PMC: 9286880. DOI: 10.1155/2022/5245256.

References
1.
Lee J, Song J . Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis. J Med Virol. 2021; 93(7):4523-4531. PMC: 8207078. DOI: 10.1002/jmv.26994. View

2.
Fung B, Gopez A, Servellita V, Arevalo S, Ho C, Deucher A . Direct Comparison of SARS-CoV-2 Analytical Limits of Detection across Seven Molecular Assays. J Clin Microbiol. 2020; 58(9). PMC: 7448668. DOI: 10.1128/JCM.01535-20. View

3.
Bordi L, Piralla A, Lalle E, Giardina F, Colavita F, Tallarita M . Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa™ COVID-19 direct assay. J Clin Virol. 2020; 128:104416. PMC: 7198196. DOI: 10.1016/j.jcv.2020.104416. View

4.
Yanson K, Laviers W, Neely L, Lockamy E, Castillo-Hernandez L, Oldfied C . Performance Evaluation of the BD SARS-CoV-2 Reagents for the BD MAX System. J Clin Microbiol. 2021; 59(12):e0101921. PMC: 8601249. DOI: 10.1128/JCM.01019-21. View

5.
Zhen W, Manji R, Smith E, Berry G . Comparison of Four Molecular Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens. J Clin Microbiol. 2020; 58(8). PMC: 7383517. DOI: 10.1128/JCM.00743-20. View